About David Bonita, M.D.
Form D filings for Mirador Therapeutics in 2024 list David Bonita, M.D. as director.
David Bonita, M.D. first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name David Bonita, M.D. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Bonita, M.D. works with at each company, as listed on that company's latest Form D.
Mirador Therapeutics, Inc. · Form D, Apr 3, 2024
PB
Paul Berns
Director
JP
Joseph Papa
Director
MM
Mark McKenna
Executive officer and director
SG
Scott Glenn
Director
KB
Kristina Burow
Director
VB
Vika Brough
Executive officer
TA
Timothy Andrews
Secretary